Docket Number:13T-920116
Inventor:Ying Hue Lee
IP Status:Know-how
Abstract:
This invention relates to the use of the gene manipulation technologies that include knockout, knockin and transgenic systems to alter the Hnf-1a gene locus in mice, so the Hnf-1a gene is inactivated in the whole body but is later activated only in liver. This is to create a new mouse strain that has normal growth and liver function in early developmental stages but has an early onset of persistent and severe diabetes.
Fields of Application:
- For use in screening drugs that can enhance insulin production and/or secretion
- For use in screening drugs that can prevent or treat diabetic complications that include hypertension, arthritis, retinal and kidney disorder
Advantages when compared to the existing technologies:
The new Hnf-1a mutant mice were not created by a simple gene knockout approach that had caused liver dysfunction, severely affected growth and health of the mice and consequently reduced the value of the mice for use in medical research for drug screening and diabetes complication study. Instead, the new Hnf-1a mutant mice were created by the combination of gene knockout, knockin and transgenic approach to modify the mouse Hnf-1a gene alleles, so the Hnf-1a gene alleles were inactivated in the cells of whole body to elicit lifelong diabetes disease, but later reactivated specifically in liver to maintain liver function to ensure the normal growth of the mice.
As a result, the new Hnf-1a mutant mice grew normally but at the same time developed severe diabetes. Most importantly, those sicknesses, such as hypertension and kidney disease, developed in the late stage of the mutant mice are largely diabetes-related and can be used in developing therapeutic strategies and in accessing the effects of treatment.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
